Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: A retrospective analysis of electronic health records

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Bloomfield, Gerald S ^a,b,c   Hogan, Joseph W ^d,e   Keter, Alfred ^e,f   Holland, Thomas L ^g   Sang, Edwin ^e,f   Kimaiyo, Sylvester ^e,f   Velazquez, Eric J ^a,b,c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY HOSPITAL   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BROWN UNIVERSITY   (United States)

^e ACADEMIC MODEL PROVIDING ACCESS TO HEALTHCARE AMPATH   (Kenya)

^f MOI UNIVERSITY   (Kenya)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Global health; HIV; Mortality; sub Saharan Africa

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; KENYA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; BLOOD; ELECTRONIC HEALTH RECORD; HYPERTENSION; INCIDENCE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; ELECTRONIC HEALTH RECORDS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; HYPERTENSION; INCIDENCE; KENYA; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84902083218     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-284     Document Type: Article

References (37)

1. Antiretroviral Therapy Cohort Collaboration Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010, 50(10):1387-1396. 3157754, 20380565, Antiretroviral Therapy Cohort Collaboration.
2. Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis 2014, 58(1):e1-34. 10.1093/cid/cit665, 24235263.
3. Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, Capeau J, Cohen A. HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol 2013, 61(5):511-523. 10.1016/j.jacc.2012.06.063, 23369416.
4. Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, Martin JN, Ganz P, Deeks SG, Hsue PY. The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease. AIDS 2012, 26(9):1115-1120. 10.1097/QAD.0b013e328352ce54, 3881548, 22382147.
5. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007, 92(7):2506-2512. 10.1210/jc.2006-2190, 2763385, 17456578.
6. Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD, . Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003, 349(21):1993-2003. Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group.
7. Triant VA. HIV infection and coronary heart disease: an intersection of epidemics. J Infect Dis 2012, 205(Suppl 3):S355-361. 10.1093/infdis/jis195, 3349293, 22577208.
8. Joint United Nations Programme on HIV/AIDS (UNAIDS) World AIDS Day Report 2012, Geneva: UNAIDS, Joint United Nations Programme on HIV/AIDS (UNAIDS).
9. Moore DM, Yiannoutsos CT, Musick BS, Tappero J, Degerman R, Campbell J, Were W, Kaharuza F, Alexander LN, Downing R, Mermim J. Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr 2011, 58(3):289-296. 10.1097/QAI.0b013e3182303716, 3774158, 21857358.
10. Gupta A, Nadkarni G, Yang W-T, Chandrasekhar A, Gupte N, Bisson GP, Hosseinipour M, Gummadi N. Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS ONE 2011, 6(12):e28691. 10.1371/journal.pone.0028691, 3248405, 22220193.
11. Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, Fox MP, Wood R, Prozesky H, Giddy J, Garone DB, Cornell M, Egger M, Boulle A, . International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med 2013, 10(4):e1001418. 10.1371/journal.pmed.1001418, 3621664, 23585736, International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration.
12. Bloomfield GS, Hogan JW, Keter A, Sang E, Carter EJ, Velazquez EJ, Kimaiyo S. Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PLoS ONE 2011, 6(7):e22288. 10.1371/journal.pone.0022288, 3136516, 21779407.
13. Rabkin M, El-Sadr WM. Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases. Glob Public Hlth 2011, 6(3):247-256.
14. Einterz RM, Kimaiyo S, Mengech HNK, Khwa-Otsyula BO, Esamai F, Quigley F, Mamlin JJ. Responding to the HIV pandemic: the power of an academic medical partnership. Acad Med 2007, 82(8):812-818. 10.1097/ACM.0b013e3180cc29f1, 17762264.
15. Yiannoutsos CT, An M-W, Frangakis CE, Musick BS, Braitstein P, Wools-Kaloustian K, Ochieng D, Martin JN, Bacon MC, Ochieng V, Kimaiyo S. Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS ONE 2008, 3(12):e3843. 10.1371/journal.pone.0003843, 2585792, 19048109.
16. World Health Organization WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children 2007, France: World Health Organization Press, World Health Organization.
17. Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT, . (CDC) CfDCaP Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. MMWR Recomm Rep 2008, 57(RR-10):1-12. (CDC) CfDCaP.
18. Robins J, Rotnitzky A, Zhao L. Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assocv 1994, 89(427):846-866.
19. Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PWF, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH. State of the science conference: initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation 2008, 118(2):198-210. 10.1161/CIRCULATIONAHA.107.189622, 3642216, 18566320.
20. Muronya W, Sanga E, Talama G, Kumwenda JJ, van Oosterhout JJ. Cardiovascular risk factors in adult Malawians on long-term antiretroviral therapy. Trans R Soc Trop Med Hyg 2011, 105(11):644-649. 10.1016/j.trstmh.2011.07.016, 21924753.
21. Meya DB, Katabira E, Otim M, Ronald A, Colebunders R, Njama D, Mayanja-Kizza H, Whalen CC, Sande M. Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting. Afr Health Sci 2007, 7(2):101-107. 1925266, 17594287.
22. Marchetti G, Bellistrì GM, Borghi E, Tincati C, Ferramosca S, La Francesca M, Morace G, Gori A, Monforte AD. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 2008, 22(15):2035-2038. 10.1097/QAD.0b013e3283112d29, 18784466.
23. Compostella C, Compostella L, D'Elia R. The symptoms of autonomic dysfunction in HIV-positive Africans. Clin Auton Res 2008, 18(1):6-12. 10.1007/s10286-007-0451-y, 18080822.
24. Okeahialam BN, Sani MU. Heart disease in HIV/AIDS. How much is due to cachexia?. Afr J Med Med Sci 2006, 35(Suppl):99-102.
25. Mateen FJ, Kanters S, Kalyesubula R, Mukasa B, Kawuma E, Kengne AP, Mills EJ. Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda. J Hypertens 2013, 31(7):1372-1378. discussion 1378, 10.1097/HJH.0b013e328360de1c, 23615323.
26. Seaberg EC, Muñoz A, Lu M, Detels R, Margolick JB, Riddler SA, Williams CM, Phair JP, Study MAC. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005, 19(9):953-960. 10.1097/01.aids.0000171410.76607.f8, 15905677.
27. Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, Martin JN, Deeks SG, Bolger AF. Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail 2010, 3(1):132-139. 10.1161/CIRCHEARTFAILURE.109.854943, 2837081, 19933410.
28. Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, Waters DD. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation 2004, 109(3):316-319. 10.1161/01.CIR.0000114520.38748.AA, 14718406.
29. Boccara F, Mary-Krause M, Teiger E, Lang S, Lim P, Wahbi K, Beygui F, Milleron O, Gabriel Steg P, Funck-Brentano C, Slama M, Girard P-M, Costagliola D, Cohen A, . Prognosis of Acute Coronary Syndrome in HIV-infected patients (PACS) Investigators Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J 2011, 32(1):41-50. 10.1093/eurheartj/ehq372, 20965887, Prognosis of Acute Coronary Syndrome in HIV-infected patients (PACS) Investigators.
30. Nyabera R, Yonga G, Mwangemi F, Bukachi F. Evaluation of a project integrating cardiovascular care into HIV programmes. Cardiovasc J Afr 2011, 22(3):S17.
31. Chillo P, Bakari M, Lwakatare J. Echocardiographic diagnoses in HIV-infected patients presenting with cardiac symptoms at Muhimbili National Hospital in Dar es Salaam, Tanzania. Cardiovasc J Afr 2012, 23(2):90-97. 10.5830/CVJA-2011-060, 3721886, 22331234.
32. Schwartz T, Girgis M, Steen TW, Sjaasatd I. HIV as a risk factor for cardiac disease in Botswana: a cross-sectional study. Cardiovasc J Afr 2011, 22(3):S23.
33. Sani MU, Muhammad S, Okeahialam BN. Effects of HAART on cardiovascular risk profile of HIV/AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Cardiovasc J Afr 2011, 22(3):S22.
34. Dillon DG, Gurdasani D, Riha J, Ekoru K, Asiki G, Mayanja BN, Levitt NS, Crowther NJ, Nyirenda M, Njelekela M, Ramaiya K, Nyan O, Adewole OO, Anastos K, Azzoni L, Boom WH, Compostella C, Dave JA, Dawood H, Erikstrup C, Fourie CM, Friis H, Kruger A, Idoko JA, Longenecker CT, Mbondi S, Mukaya JE, Mutimura E, Ndhlovu CE. Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol 2013, 42:1754-1771. 10.1093/ije/dyt198, 3887568, 24415610.
35. Alibhai A, Kipp W, Saunders LD, Senthilselvan A, Kaler A, Houston S, Konde-Lule J, Okech-Ojony J, Rubaale T. Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda. Int J Womens Health 2010, 2:45-52. 2971741, 21072296.
36. Oti SO, Mutua M, Mgomella GS, Egondi T, Ezeh A, Kyobutungi C. HIV mortality in urban slums of Nairobi, Kenya 2003-2010: a period effect analysis. BMC Public Health 2013, 13:588. 10.1186/1471-2458-13-588, 3685607, 23773503.
37. Byass P, Calvert C, Miiro-Nakiyingi J, Lutalo T, Michael D, Crampin A, Gregson S, Takaruza A, Robertson L, Herbst K, Todd J, Zaba B. InterVA-4 as a public health tool for measuring HIV/AIDS mortality: a validation study from five African countries. Glob Health Act 2013, 6:22448.